0

CARDURA XL از شرکت UPJOHN

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CARDURA XL از شرکت UPJOHN

New Drug Application (NDA): 021269

Company: UPJOHN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CARDURA XL DOXAZOSIN MESYLATE EQ 4MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription

None

Yes No
CARDURA XL DOXAZOSIN MESYLATE EQ 8MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/22/2005 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021269ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021269_carduraxl_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/22/2021 SUPPL-21 Labeling-Container/Carton Labels, Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021269Orig1s021lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021269Orig1s021ltr.pdf

02/27/2017 SUPPL-18 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021269s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021269Orig1s018ltr.pdf

06/08/2015 SUPPL-17 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021269s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021269Orig1s17ltr.pdf

07/28/2014 SUPPL-16 Manufacturing (CMC)

Label is not available on this site.

11/30/2012 SUPPL-15 Manufacturing (CMC)

Label is not available on this site.

07/08/2011 SUPPL-12 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021269s012lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021269s012ltr.pdf

03/16/2010 SUPPL-11 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021269s011lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021269s011ltr.pdf

03/24/2006 SUPPL-1 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021269s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
06/22/2021 SUPPL-21

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021269Orig1s021lbl.pdf
06/22/2021 SUPPL-21

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021269Orig1s021lbl.pdf
02/27/2017 SUPPL-18

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021269s018lbl.pdf
06/08/2015 SUPPL-17

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021269s017lbl.pdf
07/08/2011 SUPPL-12

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021269s012lbl.pdf
03/16/2010 SUPPL-11

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021269s011lbl.pdf
02/22/2005 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf
بخوانید  CETIRIZINE HYDROCHLORIDE از شرکت LANNETT CO INC
برچسب‌ها:

نظرات کاربران